Characteristics of NAFLD Among Type 2 Diabetes Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
Interventions
OTHER

Screening and studying characteristics

Type 2 diabetes patients have a high risk of developing NAFLD. This was confirmed during previous research, a high prevalence of NAFLD among type 2 diabetes mellitus patients was found. Now we want to determine the characteristics of this population.

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER